Evidence map›Paper›PMID 30723634›Full record

ArticlePeerJ2019

Taxifolin protects rat against myocardial ischemia/reperfusion injury by modulating the mitochondrial apoptosis pathway.

Zhenqiu Tang, Chunjuan Yang, Baoyan Zuo, Yanan Zhang, Gaosong Wu, Yudi Wang, Zhibin Wang

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. In Vitro Study on the Effects ofInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Zhenqiu Tang *Key Laboratory of Chinese Materia Medica, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Chunjuan Yang *College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang, China.
Baoyan ZuoSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, China.
Yanan ZhangKey Laboratory of Chinese Materia Medica, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Gaosong WuKey Laboratory of Chinese Materia Medica, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Yudi WangKey Laboratory of Chinese Materia Medica, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Zhibin WangKey Laboratory of Chinese Materia Medica, Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Heilongjiang University of Chinese Medicine · CNHarbin Medical University · CNShenyang Pharmaceutical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTaxifolin (TAX), is an active flavonoid, that plays an underlying protective role on the cardiovascular system. This study aimed to evaluate its effect and potential mechanisms on myocardial ischemia/reperfusion (I/R) injury.

methodsHealthy rat heart was subjected to I/R using the Langendorff apparatus. Hemodynamic parameters, including heart rate, left ventricular developed pressure (LVDP), maximum/minimum rate of the left ventricular pressure rise (+d

resultsTaxifolin significantly improved the ventricular functional recovery, as evident by the increase in LVDP, +d DISCUSSION: Taxifolin treatment remarkably improved the cardiac function, regulated oxidative stress and attenuated apoptosis. Hence, TAX has a cardioprotective effect against I/R injury by modulating mitochondrial apoptosis pathway.

Indexed as

ApoptosisI/RLangendorffOxidative stressTaxifolin

Identifiers

PMID30723634
PMCPMC6360081
OpenAlexW2912346102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.